GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » FCF Yield %

Noxopharm (ASX:NOX) FCF Yield % : -24.87 (As of May. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Noxopharm FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Noxopharm's Trailing 12-Month Free Cash Flow is A$-6.11 Mil, and Market Cap is A$24.55 Mil. Therefore, Noxopharm's FCF Yield % for today is -24.87%.

The historical rank and industry rank for Noxopharm's FCF Yield % or its related term are showing as below:

ASX:NOX' s FCF Yield % Range Over the Past 10 Years
Min: -73.44   Med: 0   Max: 0
Current: -24.87


ASX:NOX's FCF Yield % is ranked worse than
65.51% of 1554 companies
in the Biotechnology industry
Industry Median: -14.445 vs ASX:NOX: -24.87

Noxopharm's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Noxopharm FCF Yield % Historical Data

The historical data trend for Noxopharm's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm FCF Yield % Chart

Noxopharm Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
FCF Yield %
Get a 7-Day Free Trial -16.78 -30.74 -4.76 -24.10 -87.11

Noxopharm Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.58 -9.04 -12.76 -131.19 20.61

Competitive Comparison of Noxopharm's FCF Yield %

For the Biotechnology subindustry, Noxopharm's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noxopharm's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Noxopharm's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Noxopharm's FCF Yield % falls into.



Noxopharm FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Noxopharm's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-10.946 / 12.566234
=-87.11%

Noxopharm's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=2.138 * 2 / 20.748898
=20.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noxopharm FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Noxopharm FCF Yield % Related Terms

Thank you for viewing the detailed overview of Noxopharm's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Noxopharm (ASX:NOX) Business Description

Traded in Other Exchanges
Address
60 Linksley Ave, Glenhaven, NSW, AUS, 2156
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines